Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NRC HealthNRC -0.98%63 Debt-to-EBITDA is -20.55 as of Jun. 2026. GuruFocus rates NRC with a GF Score™ of 63/100 and a GF Value™ of $19.94 (Fairly Valued). The stock has 8 warning signs investors should review. Among 478 Healthcare Providers & Services companies, NRC Health ranks worse than 69.67% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for NRC Health's Debt-to-EBITDA or its related term are showing as below:
NRC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.03 Med: 0.66 Max: 3.84
Current: 3.84
During the past 13 years, the highest Debt-to-EBITDA Ratio of NRC Health was 3.84. The lowest was 0.03. And the median was 0.66.
NRC's Debt-to-EBITDA is ranked worse than 69.67% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.185
vs NRC: 3.84
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
NRC Health Debt-to-EBITDA Related Terms
NRC Health Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for NRC Health's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, NRC Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NRC Health Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NRC Health's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NRC Health's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
NRC Health (NRC) has a Debt-to-EBITDA of -20.55 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on NRC Health. Over the past decade, NRC Health's Debt-to-EBITDA has ranged from 0.03 to 3.84. According to the industry distribution chart, NRC Health ranks #333 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 69.7%.
Is NRC Health's Debt-to-EBITDA too high?
NRC Health's current Debt-to-EBITDA is -20.55. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 3.84. Based on the distribution chart, NRC Health ranks #333 out of 478 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NRC Health has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NRC Health's Debt-to-EBITDA compare to EVH and SOPH?
According to the Healthcare Providers & Services industry distribution chart, NRC Health ranks #333 out of 478 companies for Debt-to-EBITDA. This places NRC Health in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Historically, NRC Health's own Debt-to-EBITDA has ranged from 0.03 to 3.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on NRC Health. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NRC Health's current Debt-to-EBITDA is -20.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NRC Health stock overvalued right now?
Based on GuruFocus' analysis, NRC Health (NRC) is currently considered Fairly Valued. The stock's GF Value™ is $19.94, compared to a current price of $21.20 — trading 6.3% above its estimated fair value. The current Debt-to-EBITDA is -20.55. NRC Health's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For NRC Health (NRC), the current Debt-to-EBITDA is -20.55 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NRC Health (NRC) Overvalued in 2026?
Based on GuruFocus' analysis, NRC Health stock appears to be overvalued.
The current stock price of $21.20 is trading 6.3% above its estimated GF Value™ of $19.94.
GuruFocus considers NRC Health to be Fairly Valued.
Key valuation signals for NRC:
Debt-to-EBITDA: -20.55
GF Value™: $19.94 vs. price of $21.20 (6.3% above fair value)
No single metric tells the full story. See the NRC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
63GF Score
Get the complete analysis for NRC
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NRC has been successfully added to your 
